Spire Healthcare Group dividend and valuation
Valuation
Spire Healthcare Group paid 1.50 GBp per share in dividends over the last 12 months (yield 0.6%). Last ex-dividend date: May 21, 2026. The average price target of 4 analysts is 258.00 GBp.
Data as of November 21, 2026
Spire Healthcare Group compared with similar companies
Spire Healthcare Group's Forward P/E: 14.4, in line with the median of a group of 10 similar companies (13.8).
| Metric | Spire Healthcare Group | Median | 25th–75th percentile | Band |
|---|---|---|---|---|
| Forward P/E | 14.4 | 13.8 | 10.7 – 24.3 | Middle |
| EV/EBITDA | 11.8 | 12.7 | 10.0 – 24.8 | Middle |
| Price/book | 1.37 | 2.71 | 1.41 – 5.29 | Low |
| Price/sales | 0.63 | 1.23 | 0.65 – 4.69 | Low |
| Gross margin | 45.2% | 27.7% | 24.7% – 42.9% | High |
| Operating margin | 7.6% | 9.9% | 8.2% – 16.1% | Low |
| Net margin | -0.1% | 6.5% | 3.9% – 8.8% | Low |
| ROE | -0.2% | 10.4% | 8.1% – 16.4% | Low |
| Debt/equity | 1.80 | 0.89 | 0.45 – 1.88 | Middle |
Group: the stock and up to 10 companies in the same industry (with fewer than 5, related industries too), same region first, with a similar size. Band: low = the lowest quarter of values in the group, middle = 25th to 75th percentile, high = the highest quarter. Negative multiples and multiples above 500 are excluded; a comparison needs at least 5 values. The group is recalculated nightly.
TickerLandia analysisHow it is calculated
Companies in the group: same industry, similar size
Spire Healthcare Group: valuation over time
On the latest fiscal year's earnings (2025), Spire Healthcare Group's P/E today is 62.4, above the median of its last 7 fiscal years (41.8; between 25.4 and 108.6 from 2016 to 2025). Relative to earnings, the stock costs more than it used to. The dividend yield (0.6%) is below the median of the last 8 fiscal years (1.0%).
| Fiscal year | Price at year end | Earnings per share | P/E | Dividend per share | Yield |
|---|---|---|---|---|---|
| 2025 | £1.67 | £0.04 | 41.8 | £0.02 | 0.9% |
| 2024 | £2.26 | £0.06 | 36.5 | £0.02 | 1.0% |
| 2023 | £2.27 | £0.07 | 34.3 | £0.02 | 0.9% |
| 2022 | £2.28 | £0.02 | 108.6 | £0.01 | 0.2% |
| 2021 | £2.50 | -£0.02 | — | — | — |
| 2020 | £1.55 | -£0.58 | — | — | — |
| 2019 | £1.42 | £0.02 | 79.1 | £0.01 | 0.9% |
| 2018 | £1.09 | £0.00 | — | £0.04 | 3.5% |
| 2017 | £2.54 | £0.04 | 60.5 | £0.04 | 1.5% |
| 2016 | £3.38 | £0.13 | 25.4 | £0.04 | 1.1% |
TickerLandia calculation: closing price on the last trading day of the fiscal year divided by diluted earnings per share from the annual report (positive earnings only); yield = dividend per share for the year divided by the same price. Prices adjusted for splits. Today's P/E is today's price divided by the latest fiscal year's earnings per share, so it compares with the years above; today's yield uses dividends over the last 12 months.
TickerLandia analysisHow it is calculated
Other metrics
Valuation multiples
- Market cap
- £991.48M
- Enterprise value
- £2.27B
- P/E (trailing 12 months)
- -515.8
- PEG
- 1.37
- EV/revenue
- 1.44
Profitability and growth
- ROA
- 3.2%
- ROIC
- 3.7%
- Revenue growth (year over year)
- -0.5%
- Earnings growth (year over year)
- -283.9%
Financial health
- Total cash
- £30.4M
- Total debt
- £1.31B
- Current ratio
- 0.60
- Quick ratio
- 0.37
- Altman Z-Score
- 0.78
- Piotroski F-Score
- 4.00
Dividends
- Annual dividend per share
- 1.50 GBp
- Dividend yield
- 0.6%
- Payout ratio
- 57.5%
- Ex-dividend date
- May 21, 2026
Analysts and estimates
- Average price target
- 258.00 GBp
- Median price target
- 250.00 GBp
- High price target
- 282.00 GBp
- Low price target
- 250.00 GBp
- Analysts with a price target
- 4
- Consensus
- Buy
- Forward EPS
- 17.17 GBp
- EPS estimate, current year
- 8.22 GBp
Shares and trading
- Beta
- 0.87
- Average volume
- 2.42M
- Shares outstanding
- 400.6M
- Float
- 204.61M
- Institutional ownership
- 57.8%
- Insider ownership
- 31.5%
